Table 3.
Unadjusted |
Adjusted for Baseline eGFR
|
Adjusted for Baseline
Characteristics |
Adjusted for Baseline and
In-Hospital Characteristics |
|||||
---|---|---|---|---|---|---|---|---|
HR 95% CI | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
IRF and WRF defined using a >0.3 absolute change in creatinine | ||||||||
IRF | 2.52 (1.57–4.03) | <.001* | 2.21 (1.35–3.61) | .002* | 2.21 (1.34–3.68) | .002* | 2.19 (1.32–3.64) | .003* |
WRF | 1.17 (0.77–1.78) | .47 | 1.18 (0.78–1.79) | .44 | 1.36 (0.85–2.18) | .20 | 1.34 (0.83–2.15) | .23 |
IRF and WRF defined using a ≥20% change in eGFR | ||||||||
IRF | 2.47 (1.57–3.92) | < .001* | 2.25 (1.41–3.60) | .001* | 2.01 (1.22–3.33) | .007* | 2.08 (1.27–3.41) | .003* |
WRF | 1.30 (0.83–2.03) | .26 | 1.45 (0.91–2.31) | .11 | 1.47 (0.88–2.45) | .14 | 1.28 (0.77–2.13) | .34 |
Patients were divided into 3 renal function groups: WRF, IRF, and Stable RF. Hazard ratios are presented for WRF compared with Stable RF and IRF compared with Stable RF.
CI, confidence interval; HR, hazard ratio. Other abbreviations as in Table 1.
Significant P value.